A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)
Titel:
A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)
Auteur:
Tombal, Bertrand F. Gomez-Veiga, Francisco Gomez-Ferrer, Alvaro López-Campos, Fernando Ost, Piet Roumeguere, Thierry Andre Herrera-Imbroda, Bernardo D'Hondt, Lionel A. Quivrin, Magali Gontero, Paolo Villà, Salvador Khaled, Hussein Fournier, Beatrice Musoro, Jammbe Krzystyniak, Joanna Pretzenbacher, Yassin Loriot, Yohann